Abzena PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.07 |
Market Cap |
GBP33.74 M |
Shares Outstanding |
214.22 M |
Public Float |
170.33 M |
Address |
Babraham Research Campus Cambridge Cambridgeshire CB22 3AT United Kingdom |
Employees | - |
Website | http://abzena.com/ |
Updated | 09/14/2018 |
Abzena Plc engages in the provision of proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It operates through the following segments: Biology, Chemistry, and Biomanufacturing. Its services include: antibody discovery and candidate screening; immunology and immunogenicity assessment; antibody and protein engineering to reduce immunogenicity; and custom synthesis of cytotoxic payloads, reagents, and other small molecules. |